Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: Retrospective control study

World Journal of Surgery

Volumn 35, Issue 9, 2011, Pages 2083-2091

  Shen, W F ^a   Zhong, W ^b   Liu, Q ^a   Sui, C J ^a   Huang, Y Q ^a   Yang, J M ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CANCER STAGING; CHEMOEMBOLIZATION; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC CHOLANGIOCARCINOMA; KAPLAN MEIER METHOD; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BIOPSY, NEEDLE; CHEMOEMBOLIZATION, THERAPEUTIC; CHINA; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052262923     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1171-y     Document Type: Article

References (41)

1. HR Shin JK Oh E Masuyer, et al. 2010 Epidemiology of cholangiocarcinoma: an update focusing on risk factors Cancer Sci 101 579 585 20085587 10.1111/j.1349-7006.2009.01458.x 1:CAS:528:DC%2BC3cXjs1Kks70%3D
2. TY Lee SS Lee SW Jung, et al. 2008 Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study Am J Gastroenterol 103 1716 1720 18557716 10.1111/j.1572-0241.2008.01796.x
3. YM Zhou ZF Yin JM Yang, et al. 2008 Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China World J Gastroenterol 14 632 635 18203300 10.3748/wjg.14.632 (Pubitemid 351320834)
4. F Donato U Gelatti A Tagger, et al. 2001 Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy Cancer Causes Control 12 959 964 11808716 10.1023/A:1013747228572 1:STN:280:DC%2BD38%2Fot1GltQ%3D%3D (Pubitemid 34048878)
5. J Park MH Kim KP Kim, et al. 2009 Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study Gut Liver 3 298 305 20431764 10.5009/gnl.2009.3.4.298 1:CAS:528:DC%2BC3cXjvF2gurg%3D
6. S Jonas A Thelen C Benckert, et al. 2009 Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification Ann Surg 249 303 309 19212186 10.1097/SLA.0b013e318195e164
7. H Lang GC Sotiropoulos G Sgourakis, et al. 2009 Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients J Am Coll Surg 208 218 228 19228533 10.1016/j.jamcollsurg.2008.10.017
8. WR Jarnagin M Shoup 2004 Surgical management of cholangiocarcinoma Semin Liver Dis 24 189 199 15192791 10.1055/s-2004-828895 (Pubitemid 38738347)
9. ML DeOliveira SC Cunningham JL Cameron, et al. 2007 Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 755 762 17457168 10.1097/01.sla.0000251366.62632.d3 (Pubitemid 46684105)
10. R Robles J Figueras VS Turrión, et al. 2004 Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma Ann Surg 239 265 271 14745336 10.1097/01.sla.0000108702.45715.81 (Pubitemid 38176362)
11. GC Sotiropoulos GM Kaiser H Lang, et al. 2008 Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience Transplant Proc 40 3194 3195 19010231 10.1016/j.transproceed.2008.08. 053 1:STN:280:DC%2BD1cjktlKkuw%3D%3D
12. H Petrowsky JC Hong 2009 Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation Transplant Proc 41 4023 4035 20005336 10.1016/j.transproceed. 2009.11.001 1:STN:280:DC%2BD1Mfitlyjtg%3D%3D
13. S Mosconi GD Beretta R Labianca 2009 Cholangiocarcinoma Crit Rev Oncol Hematol 69 259 270 18977670 10.1016/j.critrevonc.2008.09.008
14. S Thongprasert 2005 The role of chemotherapy in cholangiocarcinoma Ann Oncol 16 93 96
15. F Eckel RM Schmid 2007 Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials Br J Cancer 96 896 902 17325704 10.1038/sj.bjc.6603648 1:CAS:528:DC%2BD2sXjt1SrsLw%3D (Pubitemid 46452283)
16. S Herber G Otto J Schneider, et al. 2007 Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma Cardiovasc Intervent Radiol 30 1156 1165 17508242 10.1007/s00270-007-9032-7 1:STN:280: DC%2BD2snlt1Wjsw%3D%3D (Pubitemid 350059808)
17. T Takada H Amano H Yasuda, et al. 2002 Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract: is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma Cancer 95 1685 1695 12365016 10.1002/cncr.10831
18. YY Jan CN Yeh TS Yeh 2005 Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital World J Gastroenterol 11 1779 1784 15793863
19. H Nathan TM Pawlik 2010 Staging of intrahepatic cholangiocarcinoma Curr Opin Gastroenterol 26 269 273 20179593 10.1097/MOG.0b013e328337c899 1:CAS:528:DC%2BC3cXkvVynu7g%3D
20. T Sano J Kamiya M Nagino, et al. 1999 Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 101 107 10398895 10.1007/s005340050091 1:STN:280:DyaK1MzivFemug%3D%3D
21. Y Morimoto Y Tanaka T Ito, et al. 2003 Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 432 440 14714164 10.1007/s00534-002-0842-3 (Pubitemid 38128793)
22. K Shimada T Sano Y Sakamoto 2007 Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma World J Surg 31 2016 2022 10.1007/s00268-007-9194-0 17687597 10.1007/s00268-007-9194-0 (Pubitemid 47415732)
23. KY Paik JC Jung JS Heo 2008 What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23 766 770 17868336 10.1111/j.1440-1746.2007.05040.x (Pubitemid 351519418)
24. D Tamandl B Herberger B Gruenberger 2008 Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma Ann Surg Oncol 15 2787 2794 18685896 10.1245/s10434-008-0081-1
25. T Nakagohri T Kinoshita M Konishi 2008 Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma World J Surg 32 2675 2680 10.1007/s00268-008-9778-3 18843437 10.1007/s00268-008-9778-3
26. T Uenishi S Kubo O Yamazaki, et al. 2008 Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases J Hepatobiliary Pancreat Surg 15 417 422 18670844 10.1007/s00534-007-1315-5
27. A Saiura J Yamamoto N Kokudo, et al. 2011 Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections Am J Surg 201 203 208 19427630 10.1016/j.amjsurg.2008.12. 035
28. A Guglielmi A Ruzzenente T Campagnaro, et al. 2009 Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection World J Surg 33 1247 1254 10.1007/s00268-009-9970-0 19294467 10.1007/s00268-009-9970-0
29. R Izumi K Shimizu T Iyobe, et al. 1994 Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma Hepatology 20 295 301 8045490 10.1002/hep.1840200205 1:STN:280:DyaK2czitVyltw%3D%3D (Pubitemid 24233352)
30. S Ueno G Tanabe A Yoshida 1999 Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis Cancer 86 248 254 10421260 10.1002/(SICI)1097- 0142(19990715)86:2<248::AID-CNCR8>3.0.CO;2-1 1:STN:280: DyaK1MzkslKhug%3D%3D (Pubitemid 29327581)
31. C Hong RP Guo JQ Li, et al. 2009 A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for stage III A hepatocellular carcinoma J Cancer Res Clin Oncol 135 1437 1445 10.1007/s00432-009-0588-2
32. BG Peng Q He JP Li 2009 Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus Am J Surg 198 313 318 19285298 10.1016/j.amjsurg. 2008.09.026
33. ST Kelley M Bloomston F Serafini, et al. 2004 Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy Am Surg 70 743 748 15481288 1:STN:280:DC%2BD2crhtFGntg%3D%3D
34. MH Farhat AI Shamseddine AN Tawil, et al. 2008 Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index World J Gastroenterol 14 3224 3230 18506930 10.3748/wjg.14.3224
35. Y Murakami K Uemura T Sudo, et al. 2009 Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma J Gastrointest Surg 13 1470 1479 19421824 10.1007/s11605-009-0900-0
36. SB Choi KS Kim JY Choi, et al. 2009 The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival Ann Surg Oncol 16 3048 3056 19626372 10.1245/s10434-009-0631-1
37. A Saxena TC Chua A Sarkar 2010 Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit J Gastrointest Surg 14 1128 1138 20467830 10.1007/s11605-010-1203-1
38. JH Kim HK Yoon KB Sung, et al. 2008 Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes Cancer 113 1614 1622 18704990 10.1002/cncr.23787
39. I Burger K Hong R Schulick, et al. 2005 Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution J Vasc Interv Radiol 16 353 361 15758131 10.1016/S1051- 0443(05)70320-1 (Pubitemid 40354852)
40. AF Hezel AX Zhu 2008 Systemic therapy for biliary tract cancers Oncologist 13 415 423 18448556 10.1634/theoncologist.2007-0252 1:CAS:528:DC%2BD1cXmslKksbo%3D (Pubitemid 351679921)
41. J Valle H Wasan DH Palmer, et al. 2010 ABC-02 Trial Investigators: cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273 1281 20375404 10.1056/NEJMoa0908721 1:CAS:528:DC%2BC3cXksVyiuro%3D